AAC -- Table of Contents (November 1 1997, 41 [11])

Receive this page by e-mail each issue: [Sign up for eTOCs]

Contents: November 1997, Volume 41, Issue 11

       Minireviews

       Articles

       Letters

Other Issues

FREE CONTENT FROM ASM

AUTHOR-SPONSORED OPEN ACCESS

Table of Contents

To see an article, click its [Full Text], [Abstract] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Minireviews:

Why are antibiotic resistance genes so resistant to elimination?
AA Salyers and CF Amabile-Cuevas
Antimicrob. Agents Chemother. November 1997 41: 2321-2325;
[PDF] [Reprints and Permissions]

Articles:

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
K Bartizal, CJ Gill, GK Abruzzo, AM Flattery, L Kong, PM Scott, JG Smith, CE Leighton, A Bouffard, JF Dropinski, and J Balkovec
Antimicrob. Agents Chemother. November 1997 41: 2326-2332;
[Abstract] [PDF] [Reprints and Permissions]

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
GK Abruzzo, AM Flattery, CJ Gill, L Kong, JG Smith, VB Pikounis, JM Balkovec, AF Bouffard, JF Dropinski, H Rosen, H Kropp, and K Bartizal
Antimicrob. Agents Chemother. November 1997 41: 2333-2338;
[Abstract] [PDF] [Reprints and Permissions]

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)
R Hajdu, R Thompson, JG Sundelof, BA Pelak, FA Bouffard, JF Dropinski, and H Kropp
Antimicrob. Agents Chemother. November 1997 41: 2339-2344;
[Abstract] [PDF] [Reprints and Permissions]

Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index
F Gaboriau, M Cheron, C Petit, and J Bolard
Antimicrob. Agents Chemother. November 1997 41: 2345-2351;
[Abstract] [PDF] [Reprints and Permissions]

Carbapenem resistance in a clinical isolate of Citrobacter freundii
JL Mainardi, P Mugnier, A Coutrot, A Buu-Hoi, E Collatz, and L Gutmann
Antimicrob. Agents Chemother. November 1997 41: 2352-2354;
[Abstract] [PDF] [Reprints and Permissions]

Cloning and characterization of the fmt gene which affects the methicillin resistance level and autolysis in the presence of triton X- 100 in methicillin-resistant Staphylococcus aureus
H Komatsuzawa, M Sugai, K Ohta, T Fujiwara, S Nakashima, J Suzuki, CY Lee, and H Suginaka
Antimicrob. Agents Chemother. November 1997 41: 2355-2361;
[Abstract] [PDF] [Reprints and Permissions]

Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus
M Tanaka, Y Onodera, Y Uchida, K Sato, and I Hayakawa
Antimicrob. Agents Chemother. November 1997 41: 2362-2366;
[Abstract] [PDF] [Reprints and Permissions]

In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and - resistant clinical isolates
KT Chong and PJ Pagano
Antimicrob. Agents Chemother. November 1997 41: 2367-2373;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain
M Perilli, A Felici, N Franceschini, A De Santis, L Pagani, F Luzzaro, A Oratore, GM Rossolini, JR Knox, and G Amicosante
Antimicrob. Agents Chemother. November 1997 41: 2374-2382;
[Abstract] [PDF] [Reprints and Permissions]

Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs
U Nillroth, L Vrang, PO Markgren, J Hulten, A Hallberg, and UH Danielson
Antimicrob. Agents Chemother. November 1997 41: 2383-2388;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds
Y Kashida and M Kato
Antimicrob. Agents Chemother. November 1997 41: 2389-2393;
[Abstract] [PDF] [Reprints and Permissions]

Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins
SB Tencza, JP Douglass, DJ Creighton, Jr, RC Montelaro, and TA Mietzner
Antimicrob. Agents Chemother. November 1997 41: 2394-2398;
[Abstract] [PDF] [Reprints and Permissions]

Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator
S Trepanier, A Prince, and A Huletsky
Antimicrob. Agents Chemother. November 1997 41: 2399-2405;
[Abstract] [PDF] [Reprints and Permissions]

Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae
PV Adrian and KP Klugman
Antimicrob. Agents Chemother. November 1997 41: 2406-2413;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis
I Lutsar, A Ahmed, IR Friedland, M Trujillo, L Wubbel, K Olsen, and GH McCracken, Jr
Antimicrob. Agents Chemother. November 1997 41: 2414-2417;
[Abstract] [PDF] [Reprints and Permissions]

Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms
DA Beauregard, AJ Maguire, DH Williams, and PE Reynolds
Antimicrob. Agents Chemother. November 1997 41: 2418-2423;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration
B Allaouchiche, D Breilh, H Jaumain, B Gaillard, S Renard, and MC Saux
Antimicrob. Agents Chemother. November 1997 41: 2424-2427;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy
GF Vanhove, H Kastrissios, JM Gries, D Verotta, K Park, AC Collier, K Squires, LB Sheiner, and TF Blaschke
Antimicrob. Agents Chemother. November 1997 41: 2428-2432;
[Abstract] [PDF] [Reprints and Permissions]

Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy
GF Vanhove, JM Gries, D Verotta, LB Sheiner, R Coombs, AC Collier, and TF Blaschke
Antimicrob. Agents Chemother. November 1997 41: 2433-2438;
[Abstract] [PDF] [Reprints and Permissions]

Cloning and characterization of an aminoglycoside 6'-N- acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile
HY Wu, GH Miller, MG Blanco, RS Hare, and KJ Shaw
Antimicrob. Agents Chemother. November 1997 41: 2439-2447;
[Abstract] [PDF] [Reprints and Permissions]

Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats
DL Kordick, MG Papich, and EB Breitschwerdt
Antimicrob. Agents Chemother. November 1997 41: 2448-2455;
[Abstract] [PDF] [Reprints and Permissions]

Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic
S Quan, H Venter, and ER Dabbs
Antimicrob. Agents Chemother. November 1997 41: 2456-2460;
[Abstract] [PDF] [Reprints and Permissions]

Regulation of heme polymerizing activity and the antimalarial action of chloroquine
CD Fitch and AC Chou
Antimicrob. Agents Chemother. November 1997 41: 2461-2465;
[Abstract] [PDF] [Reprints and Permissions]

Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions
O Naderer, AN Nafziger, and JS Bertino, Jr
Antimicrob. Agents Chemother. November 1997 41: 2466-2470;
[Abstract] [PDF] [Reprints and Permissions]

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors
CM Douglas, JA D'Ippolito, GJ Shei, M Meinz, J Onishi, JA Marrinan, W Li, GK Abruzzo, A Flattery, K Bartizal, A Mitchell, and MB Kurtz
Antimicrob. Agents Chemother. November 1997 41: 2471-2479;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetic interaction of megestrol acetate with zidovudine in human immunodeficiency virus-infected patients
DR Van Harken, JC Pei, J Wagner, and IM Pike
Antimicrob. Agents Chemother. November 1997 41: 2480-2483;
[Abstract] [PDF] [Reprints and Permissions]

Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase
NK Back and B Berkhout
Antimicrob. Agents Chemother. November 1997 41: 2484-2491;
[Abstract] [PDF] [Reprints and Permissions]

A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei
H Sanati, P Belanger, R Fratti, and M Ghannoum
Antimicrob. Agents Chemother. November 1997 41: 2492-2496;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model
HH Houlihan, RC Mercier, and MJ Rybak
Antimicrob. Agents Chemother. November 1997 41: 2497-2501;
[Abstract] [PDF] [Reprints and Permissions]

Comparative metabolism of the antiviral dimer 3'-azido-3'- deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes
XR Pan-Zhou, E Cretton-Scott, XJ Zhou, MY Xie, R Rahmani, RF Schinazi, K Duchin, and JP Sommadossi
Antimicrob. Agents Chemother. November 1997 41: 2502-2510;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin- tazobactam regimens
DJ Occhipinti, SL Pendland, LL Schoonover, EB Rypins, LH Danziger, and KA Rodvold
Antimicrob. Agents Chemother. November 1997 41: 2511-2517;
[Abstract] [PDF] [Reprints and Permissions]

Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs
AM Sugar, XP Liu, and RJ Chen
Antimicrob. Agents Chemother. November 1997 41: 2518-2521;
[Abstract] [PDF] [Reprints and Permissions]

Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase
I Odenholt, E Lowdin, and O Cars
Antimicrob. Agents Chemother. November 1997 41: 2522-2526;
[Abstract] [PDF] [Reprints and Permissions]

Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method
M Manduru, LB Mihm, RL White, LV Friedrich, PA Flume, and JA Bosso
Antimicrob. Agents Chemother. November 1997 41: 2527-2532;
[Abstract] [PDF] [Reprints and Permissions]

Naphthylisoquinoline alkaloids against malaria: evaluation of the curative potentials of dioncophylline C and dioncopeltine A against Plasmodium berghei in vivo
G Francois, G Timperman, W Eling, LA Assi, J Holenz, and G Bringmann
Antimicrob. Agents Chemother. November 1997 41: 2533-2539;
[Abstract] [PDF] [Reprints and Permissions]

Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa
T Kohler, M Michea-Hamzehpour, P Plesiat, AL Kahr, and JC Pechere
Antimicrob. Agents Chemother. November 1997 41: 2540-2543;
[Abstract] [PDF] [Reprints and Permissions]

Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins
T Deguchi, M Yasuda, KawamuraT , M Nakano, S Ozeki, E Kanematsu, Y Nishino, and Y Kawada
Antimicrob. Agents Chemother. November 1997 41: 2544-2546;
[Abstract] [PDF] [Reprints and Permissions]

Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244
L Bret, EB Chaibi, C Chanal-Claris, D Sirot, R Labia, and J Sirot
Antimicrob. Agents Chemother. November 1997 41: 2547-2549;
[Abstract] [PDF] [Reprints and Permissions]

Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients
K Hulten, A Gibreel, O Skold, and L Engstrand
Antimicrob. Agents Chemother. November 1997 41: 2550-2553;
[Abstract] [PDF] [Reprints and Permissions]

Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis
J Reynes, C Bazin, F Ajana, A Datry, JP Le Moing, E Chwetzoff, and JC Levron
Antimicrob. Agents Chemother. November 1997 41: 2554-2558;
[Abstract] [PDF] [Reprints and Permissions]

Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery
UK Frank, E Schmidt-Eisenlohr, D Mlangeni, M Schindler, A Hoh, F Beyersdorf, and FD Daschner
Antimicrob. Agents Chemother. November 1997 41: 2559-2561;
[Abstract] [PDF] [Reprints and Permissions]

Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro
M Menschik, J Neumuller, CW Steiner, L Erlacher, M Koller, R Ullrich, W Graninger, and WB Graninger
Antimicrob. Agents Chemother. November 1997 41: 2562-2565;
[Abstract] [PDF] [Reprints and Permissions]

Diazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cells
JR Lokensgard, G Gekker, S Hu, AF Arthur, CC Chao, and PK Peterson
Antimicrob. Agents Chemother. November 1997 41: 2566-2569;
[Abstract] [PDF] [Reprints and Permissions]

Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli
AF Ehrhardt and CC Sanders
Antimicrob. Agents Chemother. November 1997 41: 2570-2572;
[Abstract] [PDF] [Reprints and Permissions]

In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium
RC Mercier, SR Penzak, and MJ Rybak
Antimicrob. Agents Chemother. November 1997 41: 2573-2575;
[Abstract] [PDF] [Reprints and Permissions]

In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species
JA Karlowsky, GA Harding, SA Zelenitsky, DJ Hoban, A Kabani, TV Balko, M Turik, and GG Zhanel
Antimicrob. Agents Chemother. November 1997 41: 2576-2578;
[Abstract] [PDF] [Reprints and Permissions]

Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles
O Hantz, C Borel, C Trabaud, F Zoulim, J Dessolin, M Camplo, P Vlieghe, M Bouygues, C Trepo, and JL Kraus
Antimicrob. Agents Chemother. November 1997 41: 2579-2581;
[Abstract] [PDF] [Reprints and Permissions]

In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections
S Miyazaki, H Domon, K Tateda, A Ohno, Y Ishii, T Matsumoto, N Furuya, and K Yamaguchi
Antimicrob. Agents Chemother. November 1997 41: 2582-2585;
[Abstract] [PDF] [Reprints and Permissions]

In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates
RC Owens, Jr, MA Banevicius, DP Nicolau, CH Nightingale, and R Quintiliani
Antimicrob. Agents Chemother. November 1997 41: 2586-2588;
[Abstract] [PDF] [Reprints and Permissions]

Letters:

Characterization of blaTEM-3 and blaSHV-4 beta-lactamase-encoding genes in Citrobacter diversus
Z El Harrif-Heraud, C Arpin, and C Quentin
Antimicrob. Agents Chemother. November 1997 41: 2589-2590;
[PDF] [Reprints and Permissions]

Additional characteristics of Bacteroides fragilis carbapenemases belonging to group 3a
K Bush and BA Rasmussen
Antimicrob. Agents Chemother. November 1997 41: 2591-2592;
[PDF] [Reprints and Permissions]

Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia
ME Falagas
Antimicrob. Agents Chemother. November 1997 41: 2593-2594;
[PDF] [Reprints and Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.